Description (Description)
Pregabalin Capsule
Product Images NDC 80425-0277
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 80425-0277). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Label 1 (Pregabalin 80425 0277 03)
This is a package of 90 capsules containing 100mg of Pregabalin, with a comparison to a similar drug called Lyrica. It includes a product code and source number, as well as an expiration date of 12/31/2025. The name of the company that packaged it is Advancedix.*
Fig 1 (Fig 1)
Fig 10 (Fig 10)
This appears to be a table showing the estimated percentage of subjects without LTR (possibly a medical term or abbreviation) for a medication called Progabain compared to a placebo over a period of 120 to 180 days. The percentages range from 0% to 100%, with increments of 10%.*
Fig 11 (Fig 11)
Fig 12 (Fig 12)
The text shows a chart displaying the percentages of subjects who improved while taking Pregabalin and placebo medication over a course of 16 weeks. The data is presented using a numbered scale from 210 to 280 and shows that 100% of the subjects improved while taking Pregabalin. There is not enough information to provide a more detailed description.*
Fig 2 (Fig 2)
The text describes a chart or table showing the percent of patients improved with Pregabalin 160 mg within 3 days and percent improvement in pain from baseline. There are some numerical values indicated in the table such as 100, 2, 10, 220, 23, 20, 280, 2 and 23w. However, as the content is incomplete, it is difficult to derive any more information.*
Fig 3 (Fig 3)
This text appears to be a mix of numerical data and medication names, with some missing characters making it difficult to interpret accurately. Given the lack of context or further information, it is not possible to generate a useful description.*
Fig 4 (Fig 4)
Fig 5 (Fig 5)
This appears to be a chart or table showing the performance of different medications in a study. The medications listed are Fregabalin, Pregataiin, and Placebo. The dosages are also given for each medication. The chart shows that 38 patients improved, but it is not clear what they improved from or how many total patients were in the study. The last row appears to show the percent improvement in pain from baseline, but the format is difficult to interpret without more information.*
Fig 6 (Fig 6)
This document does not provide enough information for a useful description.*
Fig 7 (Fig 7)
Fig 9 (Fig 9)
The text represents a graph showing the percentage of patients improved in terms of pain, comparing the effects of Pregabalin at different daily doses and a placebo. The percentage of improvement in pain from baseline ranges from 20 to 80 percent, while the doses of Pregabalin are 300mg and 450mg daily.*
Formula (Formula)
This text appears to be a formula for calculating creatinine clearance (CLCT) using the patient's age, weight, and serum creatinine level. It is unclear what the "mmmmmmm" and "e e" parts represent, but the formula notes that a multiplication factor of 0.85 should be applied for female patients.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
